Browse By Oncolytic Virus Species Result Page of OvirusTdb

The Total number of records shown on this page is 10. Click on ID to see further detail.
IDVirus nameVirus strainVirus genome typeVirus familyVirus genome modificationVirus aloneVirus in combination with drug/radiationImmune gene insertion in viral genomeSource of cell lineOrigin of cell lineCell lineConcentration of cell lineIn-vitro toxicityAssayIn-vitro virus concentrationIn-vitro resultModel organismIn-vivo virus concentrationIn-vivo toxicityIn-vivo resultMode of deliveryPathway inducedImmunogenic effectClinical trialPMID
OV_4646Bovine herpesvirusBHV-1DNAHerpesviridaeNoneNoVirus in combination with 5-AZa (0.5 micromolar/litre)NoSt. Louis universityCotton rat tumor cell lineLCRT1.0E+5 cells per mlNAMTT assay1 MOI87% cell viablity after 2 days, additive effectNoNoNA No responseNANAInduce antitumor immune responseNA27119103
OV_4647Bovine herpesvirusBHV-1DNAHerpesviridaeNoneNoVirus in combination with 5-AZa (0.5 micromolar/litre)NoSt. Louis universityCotton rat tumor cell lineLCRT1.0E+5 cells per mlNAMTT assay3 MOI80% cell viablity after 2 days, additive effectNoNoNA No responseNANAInduce antitumor immune responseNA27119103
OV_4648Bovine herpesvirusBHV-1DNAHerpesviridaeNoneNoVirus in combination with 5-AZa (0.5 micromolar/litre)NoSt. Louis universityCotton rat tumor cell lineLCRT1.0E+5 cells per mlNAMTT assay5 MOI56% cell viablity after 2 days, additive effectNoNoNA No responseNANAInduce antitumor immune responseNA27119103
OV_4649Bovine herpesvirusBHV-1DNAHerpesviridaeNoneNoVirus in combination with 5-AZa (1.0 micromolar/litre)NoSt. Louis universityCotton rat tumor cell lineLCRT1.0E+5 cells per mlNAMTT assay1 MOI74% cell viablity after 2 days, additive effectNoNoNA No responseNANAInduce antitumor immune responseNA27119103
OV_4650Bovine herpesvirusBHV-1DNAHerpesviridaeNoneNoVirus in combination with 5-AZa (1.0 micromolar/litre)NoSt. Louis universityCotton rat tumor cell lineLCRT1.0E+5 cells per mlNAMTT assay3 MOI79% cell viablity after 2 days, additive effectNoNoNA No responseNANAInduce antitumor immune responseNA27119103
OV_4651Bovine herpesvirusBHV-1DNAHerpesviridaeNoneNoVirus in combination with 5-AZa (1.0 micromolar/litre)NoSt. Louis universityCotton rat tumor cell lineLCRT1.0E+5 cells per mlNAMTT assay5 MOI56% cell viablity after 2 days, additive effectNoNoNA No responseNANAInduce antitumor immune responseNA27119103
OV_4652Bovine herpesvirusBHV-1DNAHerpesviridaeNoneNoVirus in combination with 5-AZa (3.0 micromolar/litre)NoSt. Louis universityCotton rat tumor cell lineLCRT1.0E+5 cells per mlNAMTT assay1 MOI59% cell viablity after 2 days, additive effectNoNoNA No responseNANAInduce antitumor immune responseNA27119103
OV_4653Bovine herpesvirusBHV-1DNAHerpesviridaeNoneNoVirus in combination with 5-AZa (3.0 micromolar/litre)NoSt. Louis universityCotton rat tumor cell lineLCRT1.0E+5 cells per mlNAMTT assay3 MOI60% cell viablity after 2 days, additive effectNoNoNA No responseNANAInduce antitumor immune responseNA27119103
OV_4654Bovine herpesvirusBHV-1DNAHerpesviridaeNoneNoVirus in combination with 5-AZa (3.0 micromolar/litre)NoSt. Louis universityCotton rat tumor cell lineLCRT1.0E+5 cells per mlNAMTT assay5 MOI60% cell viablity after 2 days, additive effectNoNoNA No responseNANAInduce antitumor immune responseNA27119103
OV_4655Bovine herpesvirusBHV-1DNAHerpesviridaeNoneNoVirus in combination with 5-AZa (2mg/kg) intraperitoneal single doseNoNANANANANANANANACR mice xenograft for LCRT cells (5.0E+5)5.0E+6 pfu for 5 daysNA Combination therapy results in 3/8 animals with delayed growthIntratumoralNAInduce antitumor immune responseNA27119103